![PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies](https://www.researchgate.net/profile/Pavel-Bouchal/publication/236197462/figure/fig2/AS:393488983183361@1470826492499/Example-of-a-proteomic-experiment-designed-to-identify-protein-protein-interaction_Q320.jpg)
PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-1.jpg)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/mapka.png)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies](https://i1.rgstatic.net/publication/236197462_Identification_and_characterisation_of_pro-metastatic_targets_pathways_and_molecular_complexes_using_a_toolbox_of_proteomic_technologies/links/55ffaa8e08aeba1d9f840a24/largepreview.png)
PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies
![PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies](https://www.researchgate.net/profile/Pavel-Bouchal/publication/236197462/figure/fig1/AS:393488983183360@1470826492438/Causes-of-activation-of-NF-kB-pathway-and-the-consequences-The-stimuli-which-are-able-to_Q320.jpg)
PDF) Identification and characterisation of pro-metastatic targets, pathways and molecular complexes using a toolbox of proteomic technologies
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/untitled-21.png)
Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs
![Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice | SpringerLink Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11011-014-9550-3/MediaObjects/11011_2014_9550_Fig1_HTML.gif)
Ablation of matrix metalloproteinase-9 gene decreases cerebrovascular permeability and fibrinogen deposition post traumatic brain injury in mice | SpringerLink
![Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs Nádorové markery: Patria do koša, alebo ich vieme efektívne využiť v laboratórnej diagnostike a v klinike? | Unilabs](https://www.unilabs.sk/media/2021/12/1/5/matysova-tab-2.jpg)